A curated index of peer-reviewed longevity research, written for technical readers but accessible to anyone willing to follow the science.
Featured Paper
A high-level overview of how NAD+ pathways shift with age, why precursor supplementation has become the most-studied direct longevity intervention, and where the evidence is still uncertain.
Mitochondria
How methylene blue acts as an alternative electron carrier in impaired respiratory chains.
NAD+
Why NAD+ levels drop ~50% between ages 40 and 60, and the role of PARPs.
Clinical
What recent human pharmacokinetic and safety studies say about both NAD+ precursors.
Twelve canonical hallmarks of aging guide how we organize the research library.
DNA damage accumulation and PARP-mediated NAD+ consumption.
Electron transport chain decline and alternative carriers.
Senescent-cell accumulation and senolytic interventions.
Autophagy, chaperone function, and protein-quality control.